- Three novel MAbs will offer therapeutic advantages in autoimmune and oncology indications
Hodkinson J
- Thrombin-induced connective tissue growth factor expression in human lung fibroblasts requires ASK1/JNK/AP-1 pathway
Lin C, Yu C, Hsu M, Kuo M, Chen B
- Thrombin induces protease-activated receptor independent human platelet aggregation
Gudmundsdottir IJ, Kell JS, Megson IL, Newby DE
- Thrombin uses PAR1-dependent and -independent mechanisms to regulate the angiogenic functions of microvascular and large vessel endothelial cells
Farrar CE, Kitsche P, Herranz R, Mitchell J, Wheeler Jones CPD
- Thromboxane A2 inhibits the SKCa component of EDHF following inhibition of NO synthase in the rat middle cerebral artery
Alister J McNeishChristopher J Garland
- Thromboxane A2 release from the endothelium mediates transient P2 purinoceptor-induced contractions of the human corpus cavernosum
Faria M, LaFuente de Carvalho JM, Correia de Sa P
- Tianeptine, but not other antidepressants, improves rat brain mitochondrial efficiency
R Bains, A Markham, M Spedding, P Franklin
- Tiliroside inhibits LPS-induced acetyl-NF-kB-p65 by activating SIRT1 in BV2 microglia.
R Velagapudi, MA Aderogba, O Olajide
- Tiliroside Produced Anti-Neuroinflammatory Effects Through Interference With NF-kB And MAPK Signalling In LPS+ IFN--γ Stimulated BV-2 Microglia
R Velagapudi, O Olajide, M Aderogba
- Time course correlations of lung function, inflammation and viral titre after airways infection with parainfluenza-3
Chidgey SM, Broadley KJ
